Product Code: 2641
The U.S. home infusion therapy market is expected to grow substantially through 2032 owing to the growing preference of consumers towards at-home healthcare systems.
Advancements in technology and the increasing geriatric population across the world have further fueled the market growth. Several renowned companies in the industry are vying for overseas expansion and better opportunities to grow their business in developing states across the US.
In the region, preferences for homecare settings are changing because of increased chronic disease frequency and healthcare costs. One of the frequent inflammatory and autoimmune diseases identified in home healthcare situations is rheumatoid arthritis.
In addition to this, the home infusion therapy demand as well as I.V. infusion therapy is rising as a result of the growing number of sick people, thus positively affecting the market demand.
Furthermore, strategic initiatives like mergers, acquisitions, and product launches by leading industry players would as well expand the market scope for home infusion therapy in the United States. For instance, in September 2022, B. Braun Medical Inc., a global leader in pain management and infusion therapy, revealed the takeover of Starboard Medical, Inc.'s unique Clik-FIX catheter securement device portfolio.
With peripheral intravenous (IV) therapy, B. Braun's purchase expands on the firm's portfolio of product and program innovation to improve patient experiences and outcomes.
The U.S. home infusion therapy market has been divided in terms of product, application, and zone.
Based on the product, the IV cannulas segment is set to witness ample growth in the market through the forthcoming years. The fundamental purpose of IV cannulas is to deliver antibiotics, fluids, and blood products intravenously with an intent to enhance the condition for which a patient is being treated.
In terms of application, the U.S. home infusion therapy market has been categorized into hydration therapy, anti-infective, enteral nutrition, specialty pharmaceuticals, chemotherapy, and parenteral nutrition.
The hydration therapy segment is slated to proliferate significantly over 2023-2032. Meanwhile, the chemotherapy segment is projected to register considerable growth by the end of 2032. Furthermore, parenteral nutrition is also set to showcase a strong market share over the forecast years. The others segment is expected to expand exponentially through the review timeline.
With respect to zone, the U.S. home infusion therapy industry is diversified into east north central, west south central, east south central, west north central, and mountain states. The east-north central segment is poised to foresee steady growth through the forthcoming years. On the other hand, the mountain states segment is speculated to advance substantially by the end of 2032.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market definitions
- 1.2 Base estimates and working
- 1.3 Forecast parameters
- 1.4 Data validation
- 1.5 Data sources
- 1.5.1 Secondary
- 1.5.1.1 Paid sources
- 1.5.1.2 Unpaid sources
- 1.5.2 Primary
Chapter 2 Executive Summary
- 2.1 U.S. home infusion therapy industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Application trends
- 2.1.4 Zone trends
Chapter 3 US Home Infusion Therapy Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2018 - 2032
- 3.3 Industry impact forces
- 3.3.1 Growth drivers
- 3.3.1.1 Growing hospital acquired infections
- 3.3.1.2 Rising prevalence of chronic diseases
- 3.3.1.3 Advancements in technology
- 3.3.1.4 Growing geriatric population
- 3.3.1.5 Increasing preference towards at-home healthcare solutions
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 Safety concerns and risk of failure associated with home infusion devices
- 3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By application
- 3.5 COVID- 19 impact analysis
- 3.6 List of hospitals/clinics referring home infusion therapy
- 3.7 New drug approval scenario, 2021
- 3.7.1 Major disease indications
- 3.7.2 New drug approvals, 2010 - 2021
- 3.7.3 List of new drug approvals, 2021
- 3.8 Number of home infusion therapy patients 2018 - 2022
- 3.9 Reimbursement scenario
- 3.9.1 Public payer reimbursement scenario
- 3.9.2 Private payer reimbursement scenario
- 3.9.3 Reimbursement or billing scenario by companies
- 3.9.4 Future trends in reimbursement and billing
- 3.10 Regulatory landscape
- 3.11 Porter's analysis
- 3.11.1 Industry rivalry
- 3.11.2 Suppliers power
- 3.11.3 Buyer power
- 3.11.4 Threat of substitute
- 3.11.5 Threat of new entrants
- 3.12 PESTLE Analysis
- 3.12.1 Political
- 3.12.2 Economical
- 3.12.3 Social
- 3.12.4 Technological
- 3.12.5 Legal
- 3.12.6 Environmental
Chapter 4 Competitive Landscape, 2021
- 4.1 Introduction
- 4.2 Company matrix analysis, 2021
- 4.3 Strategy dashboard, 2021
Chapter 5 US Home Infusion Therapy Market, By Product
- 5.1 Key segment trends
- 5.2 Infusion pumps
- 5.2.1 Market size, by zone, 2018 - 2032 (USD Million)
- 5.3 Intravenous sets
- 5.3.1 Market size, by zone, 2018 - 2032 (USD Million)
- 5.4 IV Cannulas
- 5.4.1 Market size, by zone, 2018 - 2032 (USD Million)
- 5.5 Needleless connectors
- 5.5.1 Market size, by zone, 2018 - 2032 (USD Million)
Chapter 6 US Home Infusion Therapy Market, By Application
- 6.1 Key segment trends
- 6.2 Anti-infective
- 6.2.1 Market size, by zone, 2018 - 2032 (USD Million)
- 6.3 Hydration therapy
- 6.3.1 Market size, by zone, 2018 - 2032 (USD Million)
- 6.4 Chemotherapy
- 6.4.1 Market size, by zone, 2018 - 2032 (USD Million)
- 6.5 Enteral nutrition
- 6.5.1 Market size, by zone, 2018 - 2032 (USD Million)
- 6.6 Parenteral nutrition
- 6.6.1 Market size, by zone, 2018 - 2032 (USD Million)
- 6.7 Specialty pharmaceuticals
- 6.7.1 Market size, by zone, 2018 - 2032 (USD Million)
- 6.8 Others
- 6.8.1 Market size, by zone, 2018 - 2032 (USD Million)
Chapter 7 US Home Infusion Therapy Market, By Zone
- 7.1 Key zonal trends
- 7.2 East North Central
- 7.2.1 Market size, by state, 2018 - 2032 (USD Million)
- 7.2.2 Market size, by product, 2018 - 2032 (USD Million)
- 7.2.3 Market size, by application, 2018 - 2032 (USD Million)
- 7.2.4 Illinois
- 7.2.4.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.2.4.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.2.5 Indiana
- 7.2.5.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.2.5.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.2.6 Michigan
- 7.2.6.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.2.6.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.2.7 Ohio
- 7.2.7.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.2.7.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.2.8 Wisconsin
- 7.2.8.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.2.8.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.3 West South Central
- 7.3.1 Market size, by state, 2018 - 2032 (USD Million)
- 7.3.2 Market size, by product, 2018 - 2032 (USD Million)
- 7.3.3 Market size, by application, 2018 - 2032 (USD Million)
- 7.3.4 Arkansas
- 7.3.4.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.3.4.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.3.5 Louisiana
- 7.3.5.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.3.5.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.3.6 Oklahoma
- 7.3.6.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.3.6.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.3.7 Texas
- 7.3.7.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.3.7.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.4 South Atlantic
- 7.4.1 Market size, by state, 2018 - 2032 (USD Million)
- 7.4.2 Market size, by product, 2018 - 2032 (USD Million)
- 7.4.3 Market size, by application, 2018 - 2032 (USD Million)
- 7.4.4 Delaware
- 7.4.4.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.4.4.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.4.5 Florida
- 7.4.5.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.4.5.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.4.6 Georgia
- 7.4.6.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.4.6.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.4.7 Maryland
- 7.4.7.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.4.7.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.4.8 North Carolina
- 7.4.8.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.4.8.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.4.9 South Carolina
- 7.4.9.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.4.9.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.4.10 Virginia
- 7.4.10.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.4.10.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.4.11 West Virginia
- 7.4.11.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.4.11.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.4.12 Washington, D.C.
- 7.4.12.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.4.12.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.5 North East
- 7.5.1 Market size, by state, 2018 - 2032 (USD Million)
- 7.5.2 Market size, by product, 2018 - 2032 (USD Million)
- 7.5.3 Market size, by application, 2018 - 2032 (USD Million)
- 7.5.4 Connecticut
- 7.5.4.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.5.4.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.5.5 Maine
- 7.5.5.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.5.5.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.5.6 Massachusetts
- 7.5.6.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.5.6.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.5.7 New Hampshire
- 7.5.7.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.5.7.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.5.8 Rhode Island
- 7.5.8.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.5.8.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.5.9 Vermont
- 7.5.9.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.5.9.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.5.10 New Jersey
- 7.5.10.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.5.10.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.5.11 New York
- 7.5.11.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.5.11.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.5.12 Pennsylvania
- 7.5.12.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.5.12.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.6 East South Central
- 7.6.1 Market size, by state, 2018 - 2032 (USD Million)
- 7.6.2 Market size, by product, 2018 - 2032 (USD Million)
- 7.6.3 Market size, by application, 2018 - 2032 (USD Million)
- 7.6.4 Alabama
- 7.6.4.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.6.4.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.6.5 Kentucky
- 7.6.5.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.6.5.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.6.6 Mississippi
- 7.6.6.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.6.6.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.6.7 Tennessee
- 7.6.7.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.6.7.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.7 West North Central
- 7.7.1 Market size, by state, 2018 - 2032 (USD Million)
- 7.7.2 Market size, by product, 2018 - 2032 (USD Million)
- 7.7.3 Market size, by application, 2018 - 2032 (USD Million)
- 7.7.4 Iowa
- 7.7.4.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.7.4.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.7.5 Kansas
- 7.7.5.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.7.5.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.7.6 Minnesota
- 7.7.6.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.7.6.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.7.7 Missouri
- 7.7.7.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.7.7.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.7.8 Nebraska
- 7.7.8.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.7.8.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.7.9 North Dakota
- 7.7.9.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.7.9.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.7.10 South Dakota
- 7.7.10.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.7.10.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.8 Pacific Central
- 7.8.1 Market size, by state, 2018 - 2032 (USD Million)
- 7.8.2 Market size, by product, 2018 - 2032 (USD Million)
- 7.8.3 Market size, by application, 2018 - 2032 (USD Million)
- 7.8.4 Alaska
- 7.8.4.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.8.4.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.8.5 California
- 7.8.5.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.8.5.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.8.6 Hawaii
- 7.8.6.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.8.6.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.8.7 Oregon
- 7.8.7.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.8.7.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.8.8 Washington
- 7.8.8.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.8.8.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.9 Mountain States
- 7.9.1 Market size, by state, 2018 - 2032 (USD Million)
- 7.9.2 Market size, by product, 2018 - 2032 (USD Million)
- 7.9.3 Market size, by application, 2018 - 2032 (USD Million)
- 7.9.4 Arizona
- 7.9.4.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.9.4.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.9.5 Colorado
- 7.9.5.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.9.5.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.9.6 Utah
- 7.9.6.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.9.6.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.9.7 Nevada
- 7.9.7.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.9.7.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.9.8 New Mexico
- 7.9.8.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.9.8.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.9.9 Idaho
- 7.9.9.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.9.9.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.9.10 Montana
- 7.9.10.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.9.10.2 Market size, by application, 2018 - 2032 (USD Million)
- 7.9.11 Wyoming
- 7.9.11.1 Market size, by product, 2018 - 2032 (USD Million)
- 7.9.11.2 Market size, by application, 2018 - 2032 (USD Million)
Chapter 8 Company Profiles
- 8.1 B. Braun Melsungen AG
- 8.1.1 Business Overview
- 8.1.2 Financial Data
- 8.1.3 Product Landscape
- 8.1.4 Strategic Outlook
- 8.1.5 SWOT Analysis
- 8.2 Baxter International Inc.
- 8.2.1 Business Overview
- 8.2.2 Financial Data
- 8.2.3 Product Landscape
- 8.2.4 Strategic Outlook
- 8.2.5 SWOT Analysis
- 8.3 Becton Dickinson and Company
- 8.3.1 Business Overview
- 8.3.2 Financial Data
- 8.3.3 Product Landscape
- 8.3.4 Strategic Outlook
- 8.3.5 SWOT Analysis
- 8.4 Fresenius Kabi
- 8.4.1 Business Overview
- 8.4.2 Financial Data
- 8.4.3 Product Landscape
- 8.4.4 Strategic Outlook
- 8.4.5 SWOT Analysis
- 8.5 ICU Medical Inc.
- 8.5.1 Business Overview
- 8.5.2 Financial Data
- 8.5.3 Product Landscape
- 8.5.4 Strategic Outlook
- 8.5.5 SWOT Analysis
- 8.6 Terumo Corporation
- 8.6.1 Business Overview
- 8.6.2 Financial Data
- 8.6.3 Product Landscape
- 8.6.4 Strategic Outlook
- 8.6.5 SWOT Analysis
- 8.7 Moog Inc.
- 8.7.1 Business Overview
- 8.7.2 Financial Data
- 8.7.3 Product Landscape
- 8.7.4 Strategic Outlook
- 8.7.5 SWOT Analysis
- 8.8 Halyard Health, Inc. (Avanos Medical)
- 8.8.1 Business Overview
- 8.8.2 Financial Data
- 8.8.3 Product Landscape
- 8.8.4 Strategic Outlook
- 8.8.5 SWOT Analysis
- 8.9 Amsino International, Inc.
- 8.9.1 Business Overview
- 8.9.2 Financial Data
- 8.9.3 Product Landscape
- 8.9.4 Strategic Outlook
- 8.9.5 SWOT Analysis
- 8.10 Lepu Medical Technology
- 8.10.1 Business Overview
- 8.10.2 Financial Data
- 8.10.3 Product Landscape
- 8.10.4 Strategic Outlook
- 8.10.5 SWOT Analysis
- 8.11 Erenler Medikal
- 8.11.1 Business Overview
- 8.11.2 Financial Data
- 8.11.3 Product Landscape
- 8.11.4 Strategic Outlook
- 8.11.5 SWOT Analysis
- 8.12 Contec Medical Systems Co. Ltd
- 8.12.1 Business Overview
- 8.12.2 Financial Data
- 8.12.3 Product Landscape
- 8.12.4 Strategic Outlook
- 8.12.5 SWOT Analysis
- 8.13 JMS Co. Ltd.
- 8.13.1 Business Overview
- 8.13.2 Financial Data
- 8.13.3 Product Landscape
- 8.13.4 Strategic Outlook
- 8.13.5 SWOT Analysis